This excerpt taken from the UNH 8-K filed Dec 19, 2006.
i3 Operations in Latin America
i3 announced today its acquisition of one of Latin Americas largest privately held contract research organizations (CRO), with operations in Argentina, Brazil, Costa Rica, Mexico, Peru and Uruguay. This full service CRO specializes in clinical research and professional outsourcing and has a wide range of medium to large pharmaceutical and biotechnology clients. Its emphasis on quality dovetails nicely with i3s six-sigma approach to process improvement that builds in quality at all levels. i3 intends to operate the new organization as i3 Latin America.
The Latin American market is 500 million people strong and the pharmaceutical industrys demand for CRO-related services is growing rapidly there, said Nigel Page, president of i3 Research. i3 Latin America will extend i3s capabilities for our customers with known and emerging needs in Latin America and brings i3s regional strength, expertise and investment to this critical market.